EF-Hand Domain Family, Member D2 (EFHD2) (N-Term) Peptide
EFHD2
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN976165
Aperçu rapide pour EF-Hand Domain Family, Member D2 (EFHD2) (N-Term) Peptide (ABIN976165)
Antigène
EFHD2
(EF-Hand Domain Family, Member D2 (EFHD2))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Protein Region
N-Term
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-EFHD2 antibody (Catalog #: ARP58617_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
EFHD2
Reactivité: Humain, Souris
Hôte: Synthetic
BP, BI
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
EFHD2
(EF-Hand Domain Family, Member D2 (EFHD2))
Sujet
EFHD2 may regulate B-cell receptor (BCR)-induced immature and primary B-cell apoptosis. It plays a role as negative regulator of the canonical NF-kappa-B-activating branch. EFHD2 controls spontaneous apoptosis through the regulation of BCL2L1 abundance.